| Execution period | 1st June 2029 to 30th November 2029 |
|---|
NSE filing, NSE: SUNDARMFIN. Summary written from the filing by ALFA Finder's alert engine.
Sundaram Finance Ltd: key numbers
- Share price
- ₹3,924.20
- Market cap
- ₹43,599 Cr
- Revenue (annual)
- ₹9,809 Cr
- Net profit (annual)
- ₹2,059 Cr
- P/E (TTM)
- 19.6×Sector 19.7×
- Promoter holding
- 37.19%-0.02% QoQ
- FII holding
- 17.99%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sundaram Finance Ltd
All →Sundaram Finance Employee Stock Options
Sundaram Finance reported the exercise of 56 stock options granted under its 2008 ESOP scheme. Shares are being transferred from the Employees Welfare Trust.
Sundaram Finance Employee Stock Options
Sundaram Finance has informed the exchange about the exercise of 121 stock options by an employee under the ESOP scheme.
Sundaram Finance Debt & Borrowing
Sundaram Finance announced record dates for interest payments on NCDs due in November 2026. Payments are scheduled for November 26, 2026.
Sundaram Finance Employee Stock Options
Sundaram Finance Limited reported the exercise of 204 stock options by 2 option holders under its existing Employee Stock Option Scheme.
Sundaram Finance Employee Stock Options
Sundaram Finance Limited announced the exercise of 60 stock options by two employees under its 2008 Employee Stock Option Scheme.
Sundaram Finance Employee Stock Options
Sundaram Finance Limited has announced the exercise of 113 stock options granted under its Employee Stock Option Scheme.
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.